Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
F Bertolini, W Mingrone, A Alietti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 19, 2016
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy
S Caini, D Radice, G Tosti, et al.
Melanoma Research
|
October 30, 2018
A meta-analysis of melanoma risk in industrial workers
Igor Vujic, Sara Gandini, Ignazio Stanganelli, et al.
Ecancermedicalscience
|
March 17, 2016
Dabrafenib in metastatic melanoma: a monocentric 'real life' experience
E Cocorocchio, S Gandini, S Alfieri, et al.
Melanoma Research
|
May 12, 2018
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study
Paolo A Ascierto, Lars Bastholt, Pier F Ferrucci, et al.
Bone Marrow Transplantation
|
February 16, 2000
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
P F Ferrucci, A Martinoni, E Cocorocchio, et al.
Blood
|
September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein
C Nervi, F F Ferrara, M Fanelli, et al.
The EMBO Journal
|
September 16, 1996
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains
F Grignani, U Testa, D Rogaia, et al.
British Journal of Cancer
|
May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
P F Ferrucci, S Gandini, A Battaglia, et al.
British Journal of Cancer
|
March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
V Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
F Bertolini, W Mingrone, A Alietti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 19, 2016
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy
S Caini, D Radice, G Tosti, et al.
Melanoma Research
|
October 30, 2018
A meta-analysis of melanoma risk in industrial workers
Igor Vujic, Sara Gandini, Ignazio Stanganelli, et al.
Ecancermedicalscience
|
March 17, 2016
Dabrafenib in metastatic melanoma: a monocentric 'real life' experience
E Cocorocchio, S Gandini, S Alfieri, et al.
Melanoma Research
|
May 12, 2018
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study
Paolo A Ascierto, Lars Bastholt, Pier F Ferrucci, et al.
Bone Marrow Transplantation
|
February 16, 2000
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
P F Ferrucci, A Martinoni, E Cocorocchio, et al.
Blood
|
September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein
C Nervi, F F Ferrara, M Fanelli, et al.
The EMBO Journal
|
September 16, 1996
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains
F Grignani, U Testa, D Rogaia, et al.
British Journal of Cancer
|
May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
P F Ferrucci, S Gandini, A Battaglia, et al.
British Journal of Cancer
|
March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
V Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Page
of 5